Alexei Nikolaevich Marchenko

Title: Alexei Nikolaevich Marchenko: Innovator in Biotechnology

Introduction

Alexei Nikolaevich Marchenko is a prominent inventor based in Moscow, Russia. He has made significant contributions to the fields of microbiology and medical biotechnology. His work primarily focuses on genetic engineering, which has important implications for therapeutic applications.

Latest Patents

Marchenko holds a patent for "Recombinant alpha-fetoprotein and method of preparing." This invention relates to the microbiological and medical industry, specifically in genetic engineering and biotechnology. The patent describes a yeast strain developed from a recombinant plasmid DNA that includes a structural gene of human alpha-fetoprotein (AFP). This AFP is produced in a secreted soluble form, exhibiting activity that is identical or similar to that of human AFP. The recombinant AFP has potential applications as an active substance in therapeutic agents for oncology, immunotherapy, and cosmetology, as well as for diagnosing cancer and embryonic pathologies. He has 1 patent to his name.

Career Highlights

Throughout his career, Marchenko has worked in various capacities that have allowed him to advance his research and innovations. His expertise in biotechnology has positioned him as a valuable contributor to the scientific community.

Collaborations

Marchenko has collaborated with notable individuals in his field, including Sergei Vladimirovich Benevolensky and Dmitry Georgievich Kozlov. These collaborations have further enriched his research and development efforts.

Conclusion

Alexei Nikolaevich Marchenko is a key figure in the realm of biotechnology, with a focus on recombinant proteins that hold promise for medical advancements. His innovative work continues to impact the fields of oncology and immunotherapy.